Smith Hunter C — SEC Form 4 filings
SEC reporting owner CIK 1636385. 19 Form 4 filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2024-02-05 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 43 legs across 14 filings — 203,024 shares, $17,490,539 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 43.
- Largest priced transaction: sale of 28,188 shares @ $106.20 ($2,993,647) in RHYTHM PHARMACEUTICALS, INC., filed 2026-09-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Financial Officer | 19 | — | 43 legs · 203,024 sh · $17,490,539 | 43 |
Form 4 filings — Smith Hunter C
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 57,187 @ $25.79 · Sale (S): 23,072 @ $104.59 · Sale (S): 11,514 @ $105.37 · Sale (S): 28,188 @ $106.20 · Option exercise (M): 57,187 (derivative) @ $0 | EDGAR |
| 2026-05-20 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 3,000 @ $17.87 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 6,099 @ $6.80 · Option exercise (M): 6,099 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale (S): 1,200 @ $99.42 · Sale (S): 200 @ $100.52 · Sale (S): 900 @ $101.70 · Sale (S): 1,069 @ $103.00 · Sale (S): 200 @ $103.84 · Sale (S): 1,308 @ $100.27 · +3 more | EDGAR |
| 2026-02-12 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale (S): 1,913 @ $102.66 · Sale (S): 700 @ $103.68 · Sale (S): 100 @ $104.76 · Sale (S): 2,266 @ $98.37 · Sale (S): 400 @ $99.44 · Sale (S): 100 @ $100.85 · +6 more | EDGAR |
| 2026-02-06 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale (S): 1,500 @ $104.74 · Sale (S): 1,000 @ $106.60 · Sale (S): 747 @ $107.67 · Sale (S): 3,381 @ $106.06 | EDGAR |
| 2026-02-03 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 26,000 · Tax withholding (F): 10,750 @ $108.99 · Option exercise (M): 4,062 (derivative) @ $0 · Option exercise (M): 4,925 (derivative) @ $0 · Option exercise (M): 6,600 (derivative) @ $0 · Option exercise (M): 10,413 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 24,611 @ $6.88 · Sale (S): 24,611 @ $96.33 · Option exercise (M): 3,477 @ $6.88 · Sale (S): 3,477 @ $96 · Option exercise (M): 24,611 (derivative) @ $0 · Option exercise (M): 3,477 (derivative) @ $0 | EDGAR |
| 2025-07-11 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 42,120 @ $6.88 · Sale (S): 17,113 @ $75.38 · Sale (S): 1,607 @ $76.17 · Sale (S): 23,400 @ $84.50 · Option exercise (M): 42,120 (derivative) @ $0 | EDGAR |
| 2025-07-08 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 6,986 @ $6.88 · Option exercise (M): 6,986 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 23,400 @ $6.88 · Sale (S): 4,407 @ $60.93 · Sale (S): 18,993 @ $61.52 · Option exercise (M): 23,400 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 6,600 · Sale (S): 2,215 @ $57.22 · Grant/award (A): 41,650 (derivative) @ $0 · Grant/award (A): 62,500 (derivative) @ $0 · Option exercise (M): 6,600 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale (S): 739 @ $56.39 · Sale (S): 12 @ $56.22 | EDGAR |
| 2025-02-11 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 4,062 · Option exercise (M): 2,343 · Sale (S): 1,291 @ $57.51 · Sale (S): 5 @ $57.53 · Option exercise (M): 4,062 (derivative) @ $0 · Option exercise (M): 2,343 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 4,925 · Sale (S): 1,678 @ $59.43 · Option exercise (M): 4,925 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale (S): 15,515 @ $39.22 | EDGAR |
| 2024-02-21 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 33,750 @ $0 · Grant/award (A): 26,400 (derivative) @ $0 · Grant/award (A): 80,400 (derivative) @ $0 | EDGAR |
| 2024-02-13 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 4,063 · Option exercise (M): 2,344 · Sale (S): 1,209 @ $51.38 · Sale (S): 709 @ $49.82 · Option exercise (M): 4,063 (derivative) @ $0 · Option exercise (M): 2,344 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 4,925 · Sale (S): 1,616 @ $45.06 · Option exercise (M): 4,925 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1636385 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →